BARBARA BUI (BUI.PA) Fundamental Analysis & Valuation

EPA:BUI • FR0000062788

Current stock price

4 EUR
+0.2 (+5.26%)
Last:

This BUI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BUI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year BUI has reported negative net income.
  • BUI had a positive operating cash flow in the past year.
  • In multiple years BUI reported negative net income over the last 5 years.
  • In multiple years BUI reported negative operating cash flow during the last 5 years.
BUI.PA Yearly Net Income VS EBIT VS OCF VS FCFBUI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • The Return On Assets of BUI (-4.19%) is worse than 88.89% of its industry peers.
  • BUI's Return On Equity of -72.21% is on the low side compared to the rest of the industry. BUI is outperformed by 91.11% of its industry peers.
  • The Return On Invested Capital of BUI (4.45%) is worse than 62.22% of its industry peers.
Industry RankSector Rank
ROA -4.19%
ROE -72.21%
ROIC 4.45%
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
BUI.PA Yearly ROA, ROE, ROICBUI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • BUI's Operating Margin of 2.90% is on the low side compared to the rest of the industry. BUI is outperformed by 71.11% of its industry peers.
  • BUI has a Gross Margin of 74.75%. This is in the better half of the industry: BUI outperforms 80.00% of its industry peers.
  • BUI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.9%
PM (TTM) N/A
GM 74.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
BUI.PA Yearly Profit, Operating, Gross MarginsBUI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BUI.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BUI is destroying value.
  • The number of shares outstanding for BUI remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BUI has been reduced compared to 5 years ago.
  • The debt/assets ratio for BUI has been reduced compared to a year ago.
BUI.PA Yearly Shares OutstandingBUI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
BUI.PA Yearly Total Debt VS Total AssetsBUI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • BUI has an Altman-Z score of 0.85. This is a bad value and indicates that BUI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.85, BUI is doing worse than 80.00% of the companies in the same industry.
  • The Debt to FCF ratio of BUI is 19.32, which is on the high side as it means it would take BUI, 19.32 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 19.32, BUI is doing worse than 73.33% of the companies in the same industry.
  • A Debt/Equity ratio of 7.81 is on the high side and indicates that BUI has dependencies on debt financing.
  • BUI's Debt to Equity ratio of 7.81 is on the low side compared to the rest of the industry. BUI is outperformed by 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.81
Debt/FCF 19.32
Altman-Z 0.85
ROIC/WACC0.61
WACC7.28%
BUI.PA Yearly LT Debt VS Equity VS FCFBUI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • BUI has a Current Ratio of 1.00. This is a normal value and indicates that BUI is financially healthy and should not expect problems in meeting its short term obligations.
  • BUI has a worse Current ratio (1.00) than 86.67% of its industry peers.
  • A Quick Ratio of 0.67 indicates that BUI may have some problems paying its short term obligations.
  • BUI's Quick ratio of 0.67 is on the low side compared to the rest of the industry. BUI is outperformed by 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.67
BUI.PA Yearly Current Assets VS Current LiabilitesBUI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BUI.PA Growth Analysis

3.1 Past

  • BUI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.74%.
  • Looking at the last year, BUI shows a small growth in Revenue. The Revenue has grown by 6.73% in the last year.
  • Measured over the past years, BUI shows a small growth in Revenue. The Revenue has been growing by 1.80% on average per year.
EPS 1Y (TTM)-48.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.86%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%13.27%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BUI.PA Yearly Revenue VS EstimatesBUI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

2

4. BUI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • BUI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BUI.PA Price Earnings VS Forward Price EarningsBUI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 82.22% of the companies in the same industry are more expensive than BUI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.44
EV/EBITDA N/A
BUI.PA Per share dataBUI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BUI.PA Dividend Analysis

5.1 Amount

  • BUI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BUI.PA Fundamentals: All Metrics, Ratios and Statistics

BARBARA BUI

EPA:BUI (3/30/2026, 7:00:00 PM)

4

+0.2 (+5.26%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners65.34%
Ins Owner ChangeN/A
Market Cap2.68M
Revenue(TTM)13.16M
Net Income(TTM)-504.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 9.44
P/OCF 5.63
P/B 3.84
P/tB 4.97
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.42
FCFY10.6%
OCF(TTM)0.71
OCFY17.76%
SpS19.64
BVpS1.04
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.19%
ROE -72.21%
ROCE 6.05%
ROIC 4.45%
ROICexc 6.57%
ROICexgc 6.83%
OM 2.9%
PM (TTM) N/A
GM 74.75%
FCFM 2.16%
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
F-Score4
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 7.81
Debt/FCF 19.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.46%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.67
Altman-Z 0.85
F-Score4
WACC7.28%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.69%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.73%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%13.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.54%
FCF growth 3Y1.7%
FCF growth 5YN/A
OCF growth 1Y-40.72%
OCF growth 3Y-10.52%
OCF growth 5YN/A

BARBARA BUI / BUI.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BARBARA BUI?

ChartMill assigns a fundamental rating of 2 / 10 to BUI.PA.


What is the valuation status for BUI stock?

ChartMill assigns a valuation rating of 2 / 10 to BARBARA BUI (BUI.PA). This can be considered as Overvalued.


How profitable is BARBARA BUI (BUI.PA) stock?

BARBARA BUI (BUI.PA) has a profitability rating of 2 / 10.


How financially healthy is BARBARA BUI?

The financial health rating of BARBARA BUI (BUI.PA) is 2 / 10.